Obesity as assessed by body adiposity index and multivariable cardiovascular disease risk

Satvinder S Dhaliwal1, Timothy A Welborn2, Louise G H Goh1

  • 1Curtin University, Perth, Australia.

Plos One
|April 10, 2014
PubMed

Insights

Body Adiposity Index (BAI) did not effectively predict cardiovascular disease (CVD) or coronary heart disease (CHD) mortality in Australian men. Waist circumference (WC) and waist-hip ratio (WHR) were significant predictors, unlike BAI and body mass index (BMI).

Area of Science:

  • Cardiology
  • Public Health
  • Obesity Research

Background:

  • Cardiovascular disease (CVD) and coronary heart disease (CHD) remain leading causes of mortality worldwide.
  • Accurate prediction of CVD and CHD risk is crucial for effective prevention strategies.
  • Various anthropometric measures are used to assess obesity, but their comparative predictive values for mortality differ.

Purpose of the Study:

  • To evaluate the Body Adiposity Index (BAI) in predicting CVD and CHD mortality.
  • To compare the predictive performance of BAI against Body Mass Index (BMI), Waist Circumference (WC), and Waist-to-Hip Ratio (WHR).
  • To determine the effectiveness of these obesity measures after adjusting for established risk factors.

Main Methods:

  • A prospective 15-year mortality follow-up study of 4175 Australian males.
  • Exclusion criteria included pre-existing heart disease, diabetes, and stroke.
  • Multivariable logistic regression was employed to analyze the association between obesity measures and CVD/CHD mortality, with and without adjustment for Framingham Risk Scores (FRS).

Main Results:

  • The predictive ability of BAI for CVD and CHD mortality was not significant after adjustment for age and FRS.
  • BMI also showed limited predictive significance after adjustments.
  • Both WC and WHR were significant predictors of CVD and CHD mortality, maintaining significance after covariate adjustment.

Conclusions:

  • While BAI may reflect body fat percentage, it proved ineffective in predicting CVD and CHD mortality in this cohort.
  • WC and WHR emerged as superior and robust predictors of cardiovascular and coronary heart disease mortality compared to BAI and BMI.
  • These findings highlight the importance of central adiposity measures for cardiovascular risk assessment.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890